Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ifezuntirgene inilparvovec
- Development stage
- Unknown
- Lead developer
- uniQure
- Modality
- Viral Vectors → Gene Addition/Replacement → Gene Therapies, RNA Therapeutics → Nucleic Acid Therapeutics
- Administration
- Intracerebral
01
Overview
Ifezuntirgene inilparvovec is a recombinant, replication-deficient adeno-associated virus serotype 5 (AAV5) gene therapy vector. It encodes a microRNA (miRNA), specifically miHTT, which targets exon 1 of the human huntingtin protein (HTT) mRNA. The expression cassette includes a chimeric chicken beta-actin promoter and the miHTT sequence engineered in the miR-451 backbone, with an upstream region containing an inactivated miR-144 sequence and a human growth hormone polyadenylation signal, flanked by AAV2 inverted terminal repeats. The primary therapeutic goal is to reduce mutant huntingtin protein expression for the treatment of Huntington's disease.
- Other names
- Huntington's gene therapyuniQure Huntington's gene therapy
02
Targets
HTT mRNA (HTT / Huntingtin gene)
Beyond the preview
Go deeper on ifezuntirgene inilparvovec.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ifezuntirgene inilparvovec.